» Articles » PMID: 34291011

Effect of N-Acetylcysteine on the Treatment of Acute Respiratory Distress Syndrome in Mechanically Ventilated Patients Admitted to the Intensive Care Unit

Overview
Specialty General Medicine
Date 2021 Jul 22
PMID 34291011
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

N-acetylcysteine (NAC) is an antioxidant derived from the amino acid cysteine and is one of the drugs used in the treatment of respiratory diseases. The aim of this study was to investigate the effect of NAC on the treatment of acute respiratory distress syndrome in mechanically ventilated patients admitted to the intensive care unit. This study was a randomized clinical trial. Patients under mechanical ventilation admitted to the intensive care unit were examined. Patients in the intervention group received daily 150 mg/kg of NAC on the first day of admission and then 50 mg/kg up to the fourth day of admission. Patients in the control group received routine care. The vital signs, level of consciousness, and other important variables were recorded. Data were analyzed using statistical tests and SPSS software version 24. There was no significant difference between MAP, heart rate, respiratory rate, OSat, APACHE II score, and pulmonary capacity of the patients in the two groups on the first, second, third and fourth days after the intervention (p>0.05 ). There was no significant difference between the level of consciousness (according to GCS criteria), respiratory index (PAO/FIO) and PEEP of patients in the two study groups within 1 to 2 days after the intervention (p>0.05). There was a significant difference between the level of consciousness (based on GCS criteria), respiratory index (PAO/FIO) and PEEP of patients in the two study groups within 3 to 4 days after the intervention (p<0.05). There was no significant difference between the duration of hospitalization in the ICU, the time required for mechanical ventilation and the mortality rate of the patients in the two groups (p>0.05). It seems that N-acetylcysteine has a positive effect on the treatment of acute respiratory distress syndrome in mechanically ventilated patients admitted to the intensive care unit.

Citing Articles

Metabolic Regulation in Acute Respiratory Distress Syndrome: Implications for Inflammation and Oxidative Stress.

Yue L, Yan Y Int J Chron Obstruct Pulmon Dis. 2025; 20:373-388.

PMID: 39991071 PMC: 11846517. DOI: 10.2147/COPD.S491687.


Advances in the Regulation of Macrophage Polarization by Mesenchymal Stem Cells and Implications for ALI/ARDS Treatment.

Liu C, Xiao K, Xie L Front Immunol. 2022; 13:928134.

PMID: 35880175 PMC: 9307903. DOI: 10.3389/fimmu.2022.928134.

References
1.
Moradi M, Mojtahedzadeh M, Mandegari A, Soltan-Sharifi M, Najafi A, Khajavi M . The role of glutathione-S-transferase polymorphisms on clinical outcome of ALI/ARDS patient treated with N-acetylcysteine. Respir Med. 2008; 103(3):434-41. DOI: 10.1016/j.rmed.2008.09.013. View

2.
Sinha P, Flower O, Soni N . Deadspace ventilation: a waste of breath!. Intensive Care Med. 2011; 37(5):735-46. DOI: 10.1007/s00134-011-2194-4. View

3.
Zhang Y, Ding S, Li C, Wang Y, Chen Z, Wang Z . Effects of N-acetylcysteine treatment in acute respiratory distress syndrome: A meta-analysis. Exp Ther Med. 2017; 14(4):2863-2868. PMC: 5590037. DOI: 10.3892/etm.2017.4891. View

4.
Antonelli M, Conti G, Esquinas A, Montini L, Maggiore S, Bello G . A multiple-center survey on the use in clinical practice of noninvasive ventilation as a first-line intervention for acute respiratory distress syndrome. Crit Care Med. 2006; 35(1):18-25. DOI: 10.1097/01.CCM.0000251821.44259.F3. View

5.
Javaherforoosh Zadeh F, Moadeli M, Soltanzadeh M, Janatmakan F . Effect of Remote Ischemic Preconditioning on Troponin I in CABG. Anesth Pain Med. 2018; 7(4):e12549. PMC: 5797663. DOI: 10.5812/aapm.12549. View